Short answer: the eight cardarine (GW501516) before and after results below are unverified photos from 8–12-week cycles, and six of the eight people were also taking a SARM or SR9009. Human trials never measured fat loss or endurance. They measured blood fats: after 2 weeks on 10 mg a day, triglycerides fell 30%, LDL 23% and liver fat 20% (Risérus 2008). Development was stopped because cardarine caused cancers in many organs in long-term rat and mouse studies.

30%

triglycerides fell (2 weeks, 10 mg a day)

23%

LDL fell

20%

liver fat fell

This page shows the reader results with their reported cycles, the original author’s old cycle log, and what studies show for the first month and beyond, so you can judge the photos against the evidence.

Cardarine Summary

Cardarine (GW501516, GW1516) is not a SARM. It switches on PPAR-delta, a receptor that controls how muscle burns fat. GlaxoSmithKline tested it for cholesterol problems in short human trials and ended development in 2006, when long-term animal studies found toxicities “including a variety of cancers” (GSK letter via Health Canada, 2013).

Claim What the evidence says Evidence
Fat loss No human trial measured body fat or weight as an outcome. Fat burning after a meal rose and liver fat fell 20% in 2 weeks (Risérus 2008) Trial (markers only)
Endurance Raised running endurance with training in mice (Narkar 2008); never tested in people Animal
Cholesterol HDL up to +16.9% (10 mg/day), LDL −7.3% and triglycerides −16.9% over 12 weeks (Olson 2012) Trial
Cancer Two-year studies: tumors in many organs in rats at every dose tested, and liver and stomach cancers in mice (SOT 2009 abstracts) Animal
Testosterone Does not act on the androgen receptor; not measured in the human trials None in humans
Sport Banned at all times (WADA S4.4.1); WADA issued a special warning in 2013 (WADA alert) Regulator

Warning

The older version of this page said cancer only happens after a year at ten times the normal dose, and that a study “proved” cardarine fights cancer. That was wrong: the rat study found tumors at all doses, and the study it linked to was a lab test on pancreatic cancer cells. Read the full record in our cardarine fact sheet.

What the studies show: 1 month cardarine results and realistic timelines

Four human trials of cardarine have been published, lasting 2 to 12 weeks. They tracked blood fats, insulin and liver fat, not photos, weight or endurance:

Time point Dose What changed Study
2 weeks 2.5 or 10 mg/day HDL rose vs placebo; triglycerides trended down Sprecher 2007, 24 volunteers
2 weeks 10 mg/day Triglycerides −30%, apoB −26%, LDL −23%, insulin −11%, liver fat −20%; more fat burned after a meal Risérus 2008, overweight men
6 weeks 2.5 mg/day Triglycerides, apoB and VLDL down; HDL up Ooi 2011, 13 men
12 weeks 2.5, 5 or 10 mg/day HDL up to +16.9%, LDL −7.3%, triglycerides −16.9% Olson 2012, 268 adults
Doses used in human studies of Cardarine What the published studies used and found. These are research doses reported in the studies, not recommendations. Dots mark each dose a study tested (per-kg doses are listed in the table only).
Doses used in human studies of CardarineMen (2011): 2.5 mg; Healthy volunteers (2007): 2.5–10 mg; Adults (2012): 2.5–10 mg; Moderately overweight h… (2008): 10 mg0 mg5 mg10 mgMen (2011)Men (2011): 2.5 mg2.5 mgHealthy volunteers (2007)Healthy volunteers (2007): 2.5–10 mg2.5–10 mgAdults (2012)Adults (2012): 2.5–10 mg2.5–10 mgModerately overweight h… (2008)Moderately overweight h… (2008): 10 mg10 mg
Dose studiedWho took partDurationWhat the study foundSource
2.5 mg/day or 10 mg/dayHealthy volunteers, hospitalized and sedentary (n=24)2 weeksPlacebo-controlled HDL cholesterol rose on both doses while it fell 11.5% on placebo. Triglycerides trended down, and fat from a test meal was cleared faster. The authors call it the first report of a PPARδ agonist given to humans.PubMed 2007
10 mg/dayModerately overweight healthy men (6 per group; a PPARα drug and placebo were the other groups) (n=18)2 weeksRandomized, double-blind, three-group parallel Triglycerides fell 30%, apoB 26%, LDL 23%, insulin 11% and liver fat 20%. HDL did not change. Fat burning after a meal rose.PubMed 2008
2.5 mg/dayMen with central obesity and abnormal blood lipids (n=13)6 weeks per periodRandomized, double-blind, placebo-controlled crossover Triglycerides, apoB and VLDL fell. HDL cholesterol rose.PubMed 2011
2.5, 5 or 10 mg/dayAdults with low HDL cholesterol (under 1.16 mmol/L) (n=268)12 weeksPlacebo-controlled HDL rose up to 16.9% (10 mg). LDL fell 7.3%, triglycerides 16.9%, apoB 14.9% and free fatty acids 19.4%. A second study (n=37) found fewer small LDL particles.PubMed 2012

Sources: the studies linked in the table.

Embed this chart

Free to use with the credit link.

So what do “1 month cardarine results” really mean?

  • Blood changes start within 2 weeks. That is the one timeline the trials support.
  • Visible fat loss in a month comes from diet and training. No trial has shown cardarine alone causes weight or fat loss in people.
  • Six of the eight results below were stacks with ostarine, LGD-4033 or SR9009, which builds or keeps muscle and makes the “after” look leaner.
  • The doses below (15–20 mg a day) are above the highest trial dose of 10 mg.
  • Long-term risk is the issue, not the first month. The cancers appeared in two-year animal studies; nobody knows what shorter use does in people, which is why GSK said not to use it.

Cardarine Results With Before And After Pics

Editor’s note: these eight results come from the original version of this article. Readers sent them by contacting us or posted them on Reddit or Discord and allowed them to be shared; their identity, the provenance of the photos, the products and the doses could not be verified. They are unverified individual reports, not measured results, and each cycle is what the person described, not a recommendation.

A photo cannot separate fat loss from water, lighting, posing, diet, training or other compounds, so this page gives no fat or muscle figures judged from the pictures. Six of the eight results were stacks with a SARM or SR9009.

Cardarine Results #1 (+ Ostarine)

Cardarine before and after results #1 (with ostarine)

He reported an eight-week stack of cardarine and Ostarine. The after photo is leaner, but the SARM and the diet make it impossible to credit the change to cardarine.

He did not use a PCT. Ostarine lowered total testosterone even at 1–3 mg a day in trials, so “no PCT” is a personal choice, not a finding (Ostarine PCT).

Reported use: cardarine 15 mg and ostarine 10 mg a day for 8 weeks, as the person described it; not verified and not a recommendation.

Cardarine Results #2 (+ LGD 4033)

cardarine before and after – Cardarine Results #2 (+ LGD 4033)

He reported an eight-week stack of cardarine and LGD-4033 at 5 mg a day, five times the 1 mg dose that already lowered testosterone in the 21-day trial. The photos go from a softer to a more muscular look; with a SARM, diet and training involved, a photo cannot show what cardarine did. Product quality is another unknown; see where to buy SARMs.

Reported use: cardarine 15 mg and LGD-4033 5 mg a day for 8 weeks, as the person described it; not verified and not a recommendation.

Cardarine Results #3

Cardarine before and after results #3 (cardarine only)

He reported a cardarine-only cycle, eating at maintenance and training hard throughout. The after photo is leaner; without measurements, how much was fat, water or posing cannot be told from the pictures.

Reported use: cardarine 20 mg a day for 8 weeks, as the person described it; not verified and not a recommendation.

Cardarine Results #4

Cardarine before and after results #4 (cardarine only)

He reported a cardarine-only cycle. The after photo is leaner. Keep in mind that “before” pictures are often exaggerated: a pushed-out belly or a salty, sugary day beforehand can make anyone look heavier.

Reported use: cardarine 20 mg a day for 8 weeks, as the person described it; not verified and not a recommendation.

Cardarine Results #5 (+ Stenabolic)

Cardarine before and after results #5 (with SR9009)

He reported a ten-week stack of cardarine and Stenabolic (SR9009), which has never been studied in people; in the key mouse studies it was injected. The photos show a large change from very overweight to lean, which he paired with hard training and strict dieting, so neither drug’s share can be separated from the diet and training.

Reported use: cardarine 20 mg and SR9009 30 mg a day for 10 weeks, as the person described it; not verified and not a recommendation.

Cardarine Results #6 (+Ostarine)

Cardarine before and after results #6 (with ostarine)

He reported a twelve-week cycle with 30 mg of ostarine a day, ten times the highest dose tested in the 86-day ostarine trial. The after photo looks leaner and more defined.

He split his cardarine dose into 10 mg in the morning and 10 mg in the evening. There is no published human half-life to show whether splitting helps; see cardarine half-life.

Reported use: cardarine 20 mg a day (in two doses) and ostarine 30 mg a day for 12 weeks, as the person described it; not verified and not a recommendation.

He says he didn’t feel suppressed and did no PCT; he did not report bloodwork.

Cardarine Results #7 (+Ostarine)

Cardarine before and after result photo

He reported cutting with cardarine and ostarine from an already muscular build, which makes fat loss more visible in a photo.

Reported use: cardarine 20 mg and ostarine 15 mg a day for 8 weeks, as the person described it; not verified and not a recommendation.

Cardarine Results #8 (+Ostarine)

Cardarine before and after result

Both photos were taken in similar lighting, which makes the comparison fairer than most. He reported using ostarine alongside cardarine while dieting, so the change cannot be credited to cardarine alone.

Reported use: cardarine 15 mg and ostarine 20 mg a day for 8 weeks, as the person described it; not verified and not a recommendation.

My Cardarine Results

This is the original author’s own account from the earlier version of this site. It is one person’s unverified experience, without bloodwork, not evidence.

The author described several cardarine cycles, some stacked with Ostarine; the one below was cardarine only.

Reported use: cardarine 15 mg a day for 8 weeks, eating at maintenance calories, as the person described it; not verified and not a recommendation.

His goal was to go from about 17% to 10–12% body fat without losing muscle. The idea was that cardarine would increase fat burning at maintenance calories; in people that has only been shown as a rise in fat burned after a test meal, not as fat loss.

Endurance results

He reported a large rise in running endurance starting about 20 minutes after the first dose and lasting through the cycle, and compared it with Stenabolic. It was not measured: no human study has tested cardarine for endurance, and in mice the endurance effect needed training to show (Narkar 2008).

Fat Loss Results

He reported noticing fat loss from about the second week and ending at about 10–12% body fat. He trained at least four times a week and dieted throughout, so the cycle cannot show how much of the change came from cardarine.

When Does GW 50156 Kick In

When does cardarine kick in? It depends on what you are measuring:

Effect When Evidence
Blood fats (triglycerides, LDL, HDL) Within 2 weeks Trial (Risérus 2008)
Liver fat and insulin Lower after 2 weeks Trial, small (Risérus 2008)
Endurance Users report it on day one Anecdotal; in mice it needed training to show (Narkar 2008)
Visible fat loss Users report 10–14 days Anecdotal; never measured in people

Endurance Increase

Evidence

Many users report feeling more endurance within an hour of the first dose. That is anecdotal: no human study has tested cardarine and endurance, and a feeling on day one cannot tell you whether a product contains cardarine. Only a lab test can.

Users say they notice it mostly during cardio and as shorter rests between sets. These are reports, not measurements.

Fat Loss

Users report visible fat loss starting about 10–14 days into a cycle, while endurance changes are reported right away. That is anecdotal: no human study has measured fat loss on cardarine, and diet and training decide most of what shows.

Tip: take photos of yourself every week to make tracking your progress easier.

Video Results

If you prefer video, this YouTube video is one user’s account of his cardarine results and experience. It is a personal report, not medical advice.

Tips To Get The Best Results

No tip can guarantee results, but these points come from the studies rather than the photos:

  • The diet does the visible work. Cardarine’s measured effects are on blood fats, not body fat.
  • Know the cancer data before you start. The two-year rat study found tumors at every dose, and GSK stopped development because of it (SOT 2009).
  • Bloodwork: lipids, liver enzymes, fasting glucose and insulin, and CK are the markers relevant to cardarine; one case report with ostarine described severe liver and muscle damage (Kintz 2021).
  • Stacks: six of these eight results were stacks; the stack checker shows the combined risks.
  • Quality: cardarine has turned up undeclared in products sold as SARMs (JAMA 2017). If you buy, choose a shop with batch lab reports; our current pick is in the SwissChems review.

Conclusion

The cardarine before and after results on this page are unverified reports from people who look leaner after 8–12 weeks, most of them stacking it with a SARM or SR9009 and dieting hard. The human evidence for cardarine itself is narrower: better blood fats within 2 weeks and up to 12 weeks, at 2.5–10 mg a day. Fat loss and endurance in people were never measured, and long-term animal studies found cancers at every dose tested.

Compare it with other compounds in the SARMs database, see cardarine vs ostarine for fat loss, and read cardarine dosage for every dose that has been studied.

Frequently asked questions

What are realistic 1 month cardarine results?

Blood-fat changes, not fat lossEvidence: Trial

In trials, 10 mg a day lowered triglycerides 30%, LDL 23% and liver fat 20% within 2 weeks, but no human study measured fat or weight loss. Visible changes in user photos came with dieting and, usually, other compounds.

Read the full section

How much fat can you lose on cardarine?

Not established in humansEvidence: User reports

No trial measured body fat as an outcome. The reader photos on this page are unverified individual reports, mostly from people also taking a SARM or SR9009 while dieting.

Read the full section

When does cardarine kick in?

Blood fats change within 2 weeksEvidence: Trial

Blood-fat changes were measured within 2 weeks in trials. Users report more endurance on the first day and visible fat loss after 10–14 days, but those reports are anecdotal.

Read the full section

Does cardarine increase endurance?

Not tested in peopleEvidence: Animal

In mice, a PPAR-delta agonist combined with training increased running endurance. No human study has tested cardarine for endurance or performance.

Read the full section

Does cardarine cause cancer?

Yes, in animal studiesEvidence: Animal

In GSK's two-year studies, rats developed tumors in many organs at every dose tested and mice developed liver and stomach cancers. GSK ended development in 2006 because of these results, and human long-term data do not exist.

Read the full section

Is cardarine a SARM?

No, a PPAR-delta agonistEvidence: Lab

Cardarine (GW501516) does not act on the androgen receptor, so it is not expected to suppress testosterone. The human trials did not measure testosterone.

Read the full section

Is cardarine banned?

Yes, in sportEvidence: Law

WADA prohibits it at all times and issued a special warning about it in 2013. In Australia it is a Schedule 10 substance, meaning its supply and use are prohibited.

Sources

  1. Triglyceride:high-density lipoprotein cholesterol effects in healthy subjects administered a peroxisome proliferator activated receptor delta agonist 2007 · PMID 17110604
  2. Activation of peroxisome proliferator-activated receptor (PPAR)delta promotes reversal of multiple metabolic abnormalities, reduces oxidative stress, and increases fatty acid oxidation in moderately obese men 2008 · PMID 18024853
  3. Mechanism of action of a peroxisome proliferator-activated receptor (PPAR)-delta agonist on lipoprotein metabolism in dyslipidemic subjects with central obesity 2011 · PMID 21816786
  4. Lipid effects of peroxisome proliferator-activated receptor-δ agonist GW501516 in subjects with low high-density lipoprotein cholesterol: characteristics of metabolic syndrome 2012 · PMID 22814748
  5. AMPK and PPARdelta agonists are exercise mimetics 2008 · PMID 18674809
  6. Rat carcinogenicity study with GW501516, a PPAR delta agonist (Geiger et al., abstract 895) and Mouse carcinogenicity study with GW501516, a PPAR delta agonist (Newsholme et al., abstract 896), The Toxicologist 2009 2009
  7. Activation of nuclear hormone receptor peroxisome proliferator-activated receptor-delta accelerates intestinal adenoma growth 2004 · PMID 14758356
  8. Health Canada: GW501516 – Serious risks associated with use of unauthorized product (GSK letter, 24 May 2013) 2013
  9. WADA issues alert on GW501516 (21 March 2013) 2013
  10. Peroxisome Proliferator-Activated Receptor Delta Agonist (PPAR- δ) and Selective Androgen Receptor Modulator (SARM) Abuse: Clinical, Analytical and Biological Data in a Case Involving a Poisonous Combination of GW1516 (Cardarine) and MK2866 (Ostarine) 2021 · PMID 34678947
  11. Chemical Composition and Labeling of Substances Marketed as Selective Androgen Receptor Modulators and Sold via the Internet 2017 · PMID 29183075
  12. Detection of PPARδ agonists GW1516 and GW0742 and their metabolites in human urine 2012 · PMID 22977012
  13. Therapeutic Goods (Poisons Standard—June 2026) Instrument 2026 (F2026L00633) 2026
  14. WADA: The Prohibited List (2026 List, in force from 1 January 2026) 2026